Athyrium Capital Management as of March 31, 2022
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 10 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Progenity Note 7.250% 12/0 (Principal) | 26.2 | $74M | 104M | 0.71 | |
| Amryt Pharma Sponsored ADS | 26.0 | $73M | 8.9M | 8.27 | |
| Progenity | 12.3 | $35M | 30M | 1.16 | |
| Caremax Com Cl A | 11.9 | $34M | 4.5M | 7.47 | |
| Omeros Corp Note 6.250%11/1 (Principal) | 7.1 | $20M | 21M | 0.96 | |
| Rvl Pharmaceuticals SHS (RVLPQ) | 4.9 | $14M | 8.1M | 1.69 | |
| Omeros Corp Note 5.250% 2/1 (Principal) | 4.8 | $14M | 18M | 0.75 | |
| BridgeBio Pharma Note 2.250% 2/0 (Principal) | 3.4 | $9.7M | 20M | 0.48 | |
| Puma Biotechnology (PBYI) | 1.8 | $5.2M | 1.8M | 2.88 | |
| Recro Pharma (SCTL) | 1.4 | $4.0M | 2.2M | 1.80 |
